Analysis of renal transplant protocol biopsies in ABO-incompatible kidney transplantation

American Journal of Transplantation

Volumn 8, Issue 1, 2008, Pages 86-94

  Setoguchi, K ^a   Ishida, H ^a   Shimmura, H ^a   Shimizu, T ^a   Shirakawa, H ^a   Omoto, K ^a   Toki, D ^a   Iida, S ^a   Setoguchi, S ^a   Tokumoto, T ^a   Horita, S ^a   Nakayama, H ^a   Yamaguchi, Y ^b   Tanabe, K ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

ABO incompatibility; Complement C4d; Kidney transplantation; Protocol biopsies; Subclinical rejection; Transplant glomerulopathy

Indexed keywords

COMPLEMENT COMPONENT C4D;

ADULT; ARTICLE; BLOOD GROUP ABO INCOMPATIBILITY; CLINICAL PROTOCOL; DIAGNOSTIC VALUE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PRIORITY JOURNAL; RENAL GRAFT DYSFUNCTION;

ABO BLOOD-GROUP SYSTEM; ADULT; BIOPSY; BLOOD GROUP INCOMPATIBILITY; COMPLEMENT C4B; FEMALE; GRAFT REJECTION; HUMANS; KIDNEY; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 37549041377     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2007.02036.x     Document Type: Article

References (36)

1. Rush D, Nickerson P, Gough J et al. Beneficial effects of treatment of early subclinical rejection: A randomized study. J Am Soc Nephrol 1998 9 : 2129 2134.
2. Rush D, Nickerson P, Jeffery J. Protocol biopsies in the management of renal allograft recipients. Curr Opin Nephrol Hypertens 2000 9 : 615 619.
3. Nankivell B, Fenton-Lee C, Kuypers D et al. Effect of histological damage on long-term kidney transplant outcome. Transplantation 2001 71 : 515 523.
4. Rush D. Protocol biopsies should be part of the routine management of kidney transplant recipients. Am J Kidney Dis 2002 40 : 671 673.
5. Nankivell B, Chapman J. The significance of subclinical rejection and the value of protocol biopsies. Am J Transplant 2006 6 : 2006 2012.
6. Racusen L, Colvin R, Solez K et al. Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection. Am J Transplant 2003 3 : 708 714.
7. Feucht H, Mihatsch M. Diagnostic value of C4d in renal biopsies. Curr Opin Nephrol Hypertens 2005 14 : 592 598.
8. Haas M, Rahman M, Racusen L et al. C4d and C3d staining in biopsies of ABO- and HLA-incompatible renal allografts: Correlation with histologic findings. Am J Transplant 2006 6 : 1829 1840.
9. Tanabe K, Tokumoto T, Ishida H et al. Excellent outcome of ABO-incompatible living kidney transplantation under pretransplantation immunosuppression with tacrolimus, mycophenolate mofetil, and steroid. Transplant Proc 2004 36 : 2175 2177.
10. Ishida H, Miyamoto N, Shirakawa H et al. Evaluation of Immunosuppressive Regimens in ABO-Incompatible Living Kidney Transplantation-Single Center Analysis. Am J Transplant 2007 7 : 825 831.
11. Racusen L, Solez K, Colvin R et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999 55 : 713 723.
12. Solez K, Colvin R, Racusen L et al. Banff' 05 Meeting Report: Differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant 2007 7 : 518 526.
13. Gloor J, Cohen A, Lager D et al. Subclinical rejection in tacrolimus-treated renal transplant recipients. Transplantation 2002 73 : 1965 1968.
14. Moreso F, Serón D, Carrera M et al. Baseline immunosuppression is associated with histological findings in early protocol biopsies. Transplantation 2004 78 : 1064 1068.
15. Nicholson M, Bailey E, Williams S, Harris K, Furness P. Computerized histomorphometric assessment of protocol renal transplant biopsy specimens for surrogate markers of chronic rejection. Transplantation 1999 68 : 236 241.
16. Nickerson P, Jeffery J, Gough J et al. Identification of clinical and histopathologic risk factors for diminished renal function 2 years posttransplant. J Am Soc Nephrol 1998 9 : 482 487.
17. Serón D, Moreso F, Bover J et al. Early protocol renal allograft biopsies and graft outcome. Kidney Int 1997 51 : 310 316.
18. Nankivell B, Borrows R, Fung C, O'Connell P, Allen R, Chapman J. The natural history of chronic allograft nephropathy. N Engl J Med 2003 349 : 2326 2333.
19. Cosio F, Grande J, Larson T et al. Kidney allograft fibrosis and atrophy early after living donor transplantation. Am J Transplant 2005 5 : 1130 1136.
20. Cosio F, Grande J, Wadei H, Larson T, Griffin M, Stegall M. Predicting subsequent decline in kidney allograft function from early surveillance biopsies. Am J Transplant 2005 5 : 2464 2472.
21. Gloor J, Cosio F, Rea D et al. Histologic findings one year after positive crossmatch or ABO blood group incompatible living donor kidney transplantation. Am J Transplant 2006 6 : 1841 1847.
22. Mauiyyedi S, Crespo M, Collins A et al. Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classification. J Am Soc Nephrol 2002 13 : 779 787.
23. Colvin R, Smith R. Antibody-mediated organ-allograft rejection. Nat Rev Immunol 2005 5 : 807 817.
24. Mengel M, Bogers J, Bosmans J et al. Incidence of C4d stain in protocol biopsies from renal allografts: Results from a multicenter trial. Am J Transplant 2005 5 : 1050 1056.
25. Onitsuka S, Yamaguchi Y, Tanabe K, Takahashi K, Toma H. Peritubular capillary deposition of C4d complement fragment in ABO-incompatible renal transplantation with humoral rejection. Clin Transplant 1999 13 (Suppl 1 33 37.
26. Kato M, Morozumi K, Takeuchi O et al. Complement fragment C4d deposition in peritubular capillaries in acute humoral rejection after ABO blood group-incompatible human kidney transplantation. Transplantation 2003 75 : 663 665.
27. Trpkov K, Campbell P, Pazderka F, Cockfield S, Solez K, Halloran P. Pathologic features of acute renal allograft rejection associated with donor-specific antibody, Analysis using the Banff grading schema. Transplantation 1996 61 : 1586 1592.
28. Magil A, Tinckam K. Monocytes and peritubular capillary C4d deposition in acute renal allograft rejection. Kidney Int 2003 63 : 1888 1893.
29. Sund S, Hovig T, Reisaeter A, Scott H, Bentdal Ø, Mollnes T. Complement activation in early protocol kidney graft biopsies after living-donor transplantation. Transplantation 2003 75 : 1204 1213.
30. Magil A. Infiltrating cell types in transplant glomerulitis: Relationship to peritubular capillary C4d deposition. Am J Kidney Dis 2005 45 : 1084 1089.
31. Hara S, Matsushita H, Yamaguchi Y, Kawaminami K, Horita S, Furusawa M. Allograft glomerulitis: Histologic characteristics to detect chronic humoral rejection. Transplant Proc 2005 37 : 714 716.
32. Fahim T, Böhmig G, Exner M et al. The cellular lesion of humoral rejection: Predominant recruitment of monocytes to peritubular and glomerular capillaries. Am J Transplant 2007 7 : 385 393.
33. Regele H, Böhmig G, Habicht A et al. Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: A contribution of humoral immunity to chronic allograft rejection. J Am Soc Nephrol 2002 13 : 2371 2380.
34. Moreso F, Ibernon M, Gomà M et al. Subclinical rejection associated with chronic allograft nephropathy in protocol biopsies as a risk factor for late graft loss. Am J Transplant 2006 6 : 747 752.
35. Shishido S, Asanuma H, Nakai H et al. The impact of repeated subclinical acute rejection on the progression of chronic allograft nephropathy. J Am Soc Nephrol 2003 14 : 1046 1052.
36. Platt J. C4d and the fate of organ allografts. J Am Soc Nephrol 2002 13 : 2417 2419.